• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1973 - 2003年日本甲型肝炎血清流行病学的变化

Shifting seroepidemiology of hepatitis A in Japan, 1973-2003.

作者信息

Kiyohara Tomoko, Sato Tomoko, Totsuka Atsuko, Miyamura Tatsuo, Ito Toshihiro, Yoneyama Tetsuo

机构信息

Department of Virology II, National Institute of Infectious Diseases, Musashi-murayama, Tokyo, Japan.

出版信息

Microbiol Immunol. 2007;51(2):185-91. doi: 10.1111/j.1348-0421.2007.tb03900.x.

DOI:10.1111/j.1348-0421.2007.tb03900.x
PMID:17310086
Abstract

BACKGROUND

Hepatitis A infection is caused by hepatitis A virus (HAV) contracted through fecal-oral transmission. Life-long immunity is conferred after infection. Improved sanitary conditions have generally resulted in a significant decline in the incidence of hepatitis A. However, a low incidence of infection results in increased HAV susceptibility. The present study investigates the prevalence of anti-HAV antibody and clarifies the current HAV status and HAV susceptibility in Japan at 2003.

METHODS

A total of 2,430 serum specimens collected during 2003 from Japanese individuals ranging in age from 0-92 years, were tested for anti-HAV antibody using an inhibition enzyme linked immunosorbent assay. All specimens were obtained from the WHO and the National Serum Reference Bank/National Institute of Infectious Diseases, Tokyo, Japan.

RESULTS

The overall seroprevalence was 12.2%. Anti-HAV antibodies were rarely detected in individuals between 0-44 years of age. Starting from the age of 45-49 years, seropositivity gradually increased through age 65 years and above. Seroprevalence was not affected by gender, and geographic distribution did not affect age-specific seroprevalence until the age of 60 years.

CONCLUSIONS

HAV susceptibility in Japan is increasing annually. Particularly, the prevalence of anti-HAV antibody in individuals older than 50 years in 2003 was 50.3%, which is significantly lower than that of corresponding studies in 1994 (74.3%), 1984 (96.9%) and 1973 (96.9%). The growing susceptible population of advanced age results in more frequent HAV infection among them. The surveillance of anti-HAV antibody prevalence is useful for implementing preventive measures and for controlling the spread of HAV.

摘要

背景

甲型肝炎感染是由通过粪-口传播途径感染的甲型肝炎病毒(HAV)引起的。感染后可获得终身免疫。卫生条件的改善总体上导致甲型肝炎发病率显著下降。然而,低感染率导致甲型肝炎病毒易感性增加。本研究调查了抗-HAV抗体的流行情况,并阐明了2003年日本当前的甲型肝炎病毒状况和甲型肝炎病毒易感性。

方法

2003年期间从年龄在0至92岁的日本人中收集了总共2430份血清标本,使用抑制酶联免疫吸附测定法检测抗-HAV抗体。所有标本均来自世界卫生组织以及日本东京国立传染病研究所国家血清参考库。

结果

总体血清阳性率为12.2%。在0至44岁的个体中很少检测到抗-HAV抗体。从45至49岁开始,血清阳性率随着年龄增长至65岁及以上逐渐升高。血清阳性率不受性别影响,并且在60岁之前地理分布不影响年龄特异性血清阳性率。

结论

日本的甲型肝炎病毒易感性逐年增加。特别是,2003年50岁以上个体中抗-HAV抗体的流行率为50.3%,显著低于1994年(74.3%)、1984年(96.9%)和1973年(96.9%)的相应研究结果。老年易感人群的增加导致他们中甲型肝炎病毒感染更为频繁。对抗-HAV抗体流行率的监测有助于实施预防措施并控制甲型肝炎病毒的传播。

相似文献

1
Shifting seroepidemiology of hepatitis A in Japan, 1973-2003.1973 - 2003年日本甲型肝炎血清流行病学的变化
Microbiol Immunol. 2007;51(2):185-91. doi: 10.1111/j.1348-0421.2007.tb03900.x.
2
Reduced Seroprevalence of Hepatitis A Virus Among Japanese Healthcare Workers as a Risk Factor for Occupational Infection.日本医护人员甲型肝炎病毒血清阳性率降低作为职业感染的危险因素
Clin Lab. 2018 Oct 1;64(10):1791-1793. doi: 10.7754/Clin.Lab.2018.180518.
3
Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan.过去20年日本幽门螺杆菌和甲型肝炎病毒血清流行病学模式的变化。
Am J Gastroenterol. 1999 Aug;94(8):2094-9. doi: 10.1111/j.1572-0241.1999.01283.x.
4
Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance.阿根廷中部地区甲型肝炎病毒流行的证据:血清流行率和环境监测。
J Clin Virol. 2014 Jan;59(1):38-43. doi: 10.1016/j.jcv.2013.11.005. Epub 2013 Nov 23.
5
Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.来自社会经济地位较低群体的儿童中甲型肝炎病毒抗体流行率下降,这强化了在巴西实施甲型肝炎疫苗接种的必要性。
Mem Inst Oswaldo Cruz. 2012 Aug;107(5):652-8. doi: 10.1590/s0074-02762012000500012.
6
Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study.意大利慢性肝病患者甲型肝炎病毒感染情况的多中心研究
J Viral Hepat. 2006 Jan;13(1):67-71. doi: 10.1111/j.1365-2893.2005.00659.x.
7
Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan.台湾地区学童甲型肝炎病毒感染的血清流行病学研究。
J Med Virol. 2011 Feb;83(2):196-200. doi: 10.1002/jmv.22000.
8
Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.印度海得拉巴市甲型肝炎病毒抗体的年龄相关血清流行率。
Trop Gastroenterol. 2000 Apr-Jun;21(2):63-5.
9
Hepatitis A virus subgenotypes dissemination during a community outbreak in a surrounding region of Rio de Janeiro.甲型肝炎病毒亚基因型在里约热内卢周边地区社区疫情期间的传播情况。
Mem Inst Oswaldo Cruz. 2008 May;103(3):254-8. doi: 10.1590/s0074-02762008000300005.
10
The seroepidemiology of hepatitis A and B in a Japanese town.日本某城镇甲型和乙型肝炎的血清流行病学
Asia Pac J Public Health. 1992;6(2):26-9. doi: 10.1177/101053959300600204.

引用本文的文献

1
Hepatitis A outbreak among men who have sex with men, Shinjuku, Japan, 2018.2018年,日本新宿,男男性行为者中爆发甲型肝炎疫情。
Western Pac Surveill Response J. 2025 Feb 25;16(1):1-10. doi: 10.5365/wpsar.2025.16.1.1088. eCollection 2025 Jan-Mar.
2
Hepatitis A epidemics in Japan, France, and Thailand from 2007 to 2021, highlighting a post-COVID-19 decline.2007年至2021年日本、法国和泰国的甲型肝炎疫情,突显了新冠疫情后的下降情况。
Sci Rep. 2025 Feb 28;15(1):7228. doi: 10.1038/s41598-025-91499-7.
3
The Shifting Epidemiology of Hepatitis A in the World Health Organization Western Pacific Region.
世界卫生组织西太平洋区域甲型肝炎流行病学的变化
Vaccines (Basel). 2024 Feb 16;12(2):204. doi: 10.3390/vaccines12020204.
4
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs.日本血友病患者中针对腺相关病毒衣壳的中和抗体血清阳性率。
Mol Ther Methods Clin Dev. 2022 Oct 27;27:404-414. doi: 10.1016/j.omtm.2022.10.014. eCollection 2022 Dec 8.
5
Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.突尼斯中西部地区甲型肝炎病毒感染:传播和疫苗接种影响的年龄结构模型。
BMC Infect Dis. 2020 Aug 26;20(1):627. doi: 10.1186/s12879-020-05318-7.
6
Sero-prevalence of viral hepatitis A in a district of Sri Lanka: a community based cross-sectional study.斯里兰卡一个地区甲型肝炎病毒血清流行率:一项基于社区的横断面研究。
BMC Infect Dis. 2019 May 21;19(1):443. doi: 10.1186/s12879-019-4043-y.
7
Very low prevalence of anti-HAV in Japan: high potential for future outbreak.日本甲型肝炎抗体的极低流行率:未来爆发的高潜力。
Sci Rep. 2019 Feb 6;9(1):1493. doi: 10.1038/s41598-018-37349-1.
8
Usability of the international HAVNet hepatitis A virus database for geographical annotation, backtracing and outbreak detection.国际 HAVNet 甲型肝炎病毒数据库在地理注释、溯源和暴发检测方面的可用性。
Euro Surveill. 2018 Sep;23(37). doi: 10.2807/1560-7917.ES.2018.23.37.1700802.
9
Prevalence of G6PD deficiency in Children with Hepatitis A.甲型肝炎患儿中葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症的患病率
Int J Hematol Oncol Stem Cell Res. 2017 Apr 1;11(2):92-95.
10
Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products.静脉注射免疫球蛋白产品中抗甲型肝炎病毒和乙型肝炎病毒的抗体
J Korean Med Sci. 2016 Dec;31(12):1937-1942. doi: 10.3346/jkms.2016.31.12.1937.